EVALUASI KADAR GLUKOSA DARAH PASIEN DIABETES MELITUS TIPE 2 DENGAN HIPERTENSI DI RUANG CEMPAKA RUMAH SAKIT PANTI WILASA CITARUM SEMARANG
DOI:
https://doi.org/10.61740/jcp2s.v1i1.5Keywords:
Panti Wilasa Citarum Hospital Semarang., GDP, GD2JPP, Type 2 Diabetes MellitusAbstract
Diabetes mellitus is a degenerative disease that increases every year in the world. The most common case of DM is a case of type 2 DM (90%). Type 2 DM with hypertension is one of the ten biggest diseases in Panti Wilasa Citarum Hospital Semarang. The purpose of this study was to evaluate and calculate the value of decreasing blood glucose levels. The type of research conducted was descriptive observational using a prospective method. The study was conducted in Cempaka Room at Panti Wilasa Citarum Hospital Semarang in the period March-April 2019. The research subjects were patients aged 18-60 years with National Health Insurance who met the inclusion-exclusion criteria who were willing to be respondents in this study. Data is processed and analyzed qualitatively and quantitatively. The results showed that the target blood glucose level of type 2 DM patients with hypertension at Panti Wilasa Citarum Hospital Semarang was achieved. Patients experienced a decrease in GD2JPP and GDP levels in single antidiabetic therapy of 73.68%, two combinations of antidiabetic 95%, three combinations of antidiabetic 100%.
References
American Diabetes Association (ADA), 2018. Classification and Diagnosis of Diabetes Mellitus. Diabetes Care Journal. Vol. 41. pp. 28-37.
Cahyani, I.C., Kusumaningrum, N.S.S.D., dkk, 2017. Karakteristik Ibu Hamil Dengan Hiperglikemia. ISSN. 1475-362846. Vol. 1. pp. 1-12
Dipiro, J.T., Wells B.G., Schwinghammer, T.L., Dipiro C.V., 2009. Pharmacotherapy Handbook.7ed. McGraw-Hill Companies. United States
Hongdiyanto, A., dkk. 2013. Evaluasi Kerasionalan Pengobatan DM Tipe 2 Pada Pasien Rawat Inap Di RSUP Prof. dr.R. D. Kandou Manado. ISSN. Vol. 3. pp. 2302-2493
International Diabetes Federation (IDF), 2017.IDF Diabetes Atlas 8th Edition. IDF: Belgium.
Katzung, B.G., 2012. Farmakologi dasar dan klinik edisi 12. Penerbit Buku EGC : Jakarta.
Kementrian Kesehatan, 2018. Riset Kesehatan Dasar (Riskesdas) 2018. Badan Penelitian dan Pengembangan Kesehatan Kementerian RI: Jakarta.
Perkumpulan Endokrinologi Indonesia (Perkeni), 2015. Konsensus Pengelolaan dan Pencegahan Diabetes MelitusTipe 2 di Indonesia. PERKENI: Jakarta.
Rahayuningsih, N., dkk, 2018. Evaluasi Penggunaan Obat Antidiabetes Mellitus Tipe II Komplikasi Hipertensi Pada Pasien Rawat Inap Di RSUD Dr. Soekardjo Kota Tasikmalaya.ISBN:978-602-72636-3-5.
Rochmah W., 2009. Diabetes Mellitus pada usia Lanjut edisi 5. Penerbit Buku IPD FKUI, Jakarta.
Sweetman, S et al, 2009. Martindale 36th. The Pharmaceutical. Press: London.
World Health Organization (WHO). 2016. Global Report On Diabetes. WHO: France.